These were selected based on previously reported functions that correlated with any of the known roles for MASTL (e.g., mitosis, EMT, cancer), the availability of commercial recombinant purified protein and those with the highest Log2 fold-change from our SILAC screen. The gene discussed is MASTL; the disease is cancer.